Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins

The humoral immune response to four intracellularly located cytomegalovirus (CMV) proteins was studied in 15 lung transplant recipients experiencing active CMV infections. Five patients had primary infections, and 10 had secondary infections. Antibodies of the immunoglobulin M (IgM) and IgG classes were measured in an enzyme-linked immunosorbent assay (ELISA) system in which procaryotically expressed recombinant proteins were used as a substrate and also in a monoclonal antibody-based capture ELISA which uses naturally occurring proteins as a substrate. The proteins investigated were the lower matrix protein pp65 (ppUL83), the major DNA-binding protein p52 (ppUL44), and the two immediate early proteins IE1 and IE2 (different splicing products of UL123). Higher levels of antibodies were found to pp65 and especially to p52 than to the immediate early antigens. Antibody levels detected in the recombinant protein-based ELISAs were generally lower than antibody responses detected with the matching antigen capture ELISA. Moreover, some patients appeared to have antibodies mainly to epitopes present on naturally occurring proteins. The antibody responses detected in both assays were related to the viral load during infection as assessed by the CMV antigenemia test, which is a quantitative marker for CMV load. It was found that although epitopes on naturally occurring proteins induce higher antibody responses and responses in more patients, antibodies directed to epitopes present on the recombinant proteins were inversely related to the viral load during a CMV infection. Therefore, antibodies to epitopes on the recombinant proteins might be more clinically relevant in this group of lung transplant recipients.

[1]  M. Landini,et al.  An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomegalovirus , 1993, Journal of medical virology.

[2]  T. Lazzarotto,et al.  Humoral immune response to human cytomegalovirus DNA polymerase , 1993, Journal of clinical microbiology.

[3]  M. van der Giessen,et al.  Antibody responses to human cytomegalovirus‐specific polypeptides studied by immunoblotting in relation to viral load during cytomegalovirus infection , 1993, Journal of medical virology.

[4]  B. Plachter,et al.  The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. , 1992, The Journal of general virology.

[5]  A. Necker,et al.  Large-scale screening of human sera with cytomegalovirus recombinant antigens , 1990, Journal of clinical microbiology.

[6]  M. van der Giessen,et al.  Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation--a report of 130 consecutive patients. , 1989, Transplantation.

[7]  W. Ho,et al.  Humoral immune response to cytomegalovirus Towne vaccine strain and to Toledo low-passage strain. , 1989, The Journal of infectious diseases.

[8]  L. de Leij,et al.  Determination of human antibodies to specific antigens of cytomegalovirus using an antigen capture immunoassay. , 1989, Journal of immunological methods.

[9]  J. Sissons,et al.  Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses , 1988, The Journal of experimental medicine.

[10]  W. V. van Son,et al.  Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes , 1988, Journal of medical virology.

[11]  S. Jonjić,et al.  A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection , 1988, Journal of virology.

[12]  H. Handsfield,et al.  Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection. , 1988, The Journal of infectious diseases.

[13]  M. Landini,et al.  Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting , 1985, Journal of medical virology.

[14]  N. Cremer,et al.  Antibody response to cytomegalovirus polypeptides captured by monoclonal antibodies on the solid phase in enzyme immunoassays , 1985, Journal of clinical microbiology.

[15]  P. Tijssen,et al.  Practice and theory of enzyme immunoassays , 1985 .